This modulation ultimately leads to a suppression of the production and secretion of inflammatory cytokines, including TNF-α, IL-1β, and IL-6, thereby regulating inflammatory reactions and mitigating tissue damage in T cell-mediated autoimmune diseases, such as RA, MS, and inflammatory bowel disease (218). The gene discussed is TNF; the disease is myeloid sarcoma.